CLDN18 and lung adenocarcinoma: Overexpression of miR-767-5p promoted cell progression by directly targeting and regulating MAPK4 (38), while miR-767-3p inhibited the growth and migration of lung adenocarcinoma cells by regulating CLDN18 (39).